Kayne Anderson Rudnick Investment Management LLC Olema Pharmaceuticals, Inc. Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$2.04 - $4.61 $261 - $590	-128 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.89 - $9.43 $497 - $1,207	128 New	128 $1,000

Others Institutions Holding OLMA

# of Institutions

136

Shares Held

58.7M

Call Options Held

141K

Put Options Held

23.1K

Bvf Inc San Francisco, CA

9.14M
Shares

$91.4 Million
3.47% of portfolio
Paradigm Biocapital Advisors LP New York, NY

5.5M
Shares

$55 Million
2.37% of portfolio
Deep Track Capital, LP Greenwich, CT

4M
Shares

$40 Million
1.76% of portfolio
Black Rock Inc. New York, NY

4M
Shares

$40 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

3.69M
Shares

$36.9 Million
0.12% of portfolio

View Full List

About Olema Pharmaceuticals, Inc.

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $404M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

More about OLMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account